Financial Review: Steakholder Foods (OTCMKTS:MTTCF) and Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) and Steakholder Foods (OTCMKTS:MTTCF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings.

Insider and Institutional Ownership

93.8% of Embecta shares are held by institutional investors. 0.4% of Embecta shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Embecta and Steakholder Foods”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.12 billion	0.97	$78.30 million	$1.35	13.83
Steakholder Foods	N/A	N/A	N/A	N/A	N/A

Embecta has higher revenue and earnings than Steakholder Foods.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Embecta and Steakholder Foods, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0	1	1	0	2.50
Steakholder Foods	0	0	0	0	0.00

Embecta presently has a consensus price target of $23.00, indicating a potential upside of 23.17%. Given Embecta’s stronger consensus rating and higher probable upside, analysts clearly believe Embecta is more favorable than Steakholder Foods.

Profitability

This table compares Embecta and Steakholder Foods’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Embecta	6.97%	-18.54%	11.43%
Steakholder Foods	N/A	N/A	N/A

Summary

Embecta beats Steakholder Foods on 8 of the 9 factors compared between the two stocks.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

About Steakholder Foods

Steakholder Foods Ltd., a deep-tech food company, develops cultivated meat production technologies in Israel. The company develops alternative protein manufacturing machines, including three-dimensional printers to produce meat, fish, and seafood analogs; and hybrid cultivated meat technologies to be integrated into production processes, as well as hybrid meat blends, cell lines, growth media, and bioreactors. It also offers premix blends as a plant-based alternative for meat and seafood under the SHMeat and SHFish brand names. In addition, the company provides consulting and implementation services. It serves food processing and retail companies; and cultivated meat producers. Steakholder Foods Ltd. was founded in 2019 and is headquartered in Rehovot, Israel.